Scotiabank Remains a Buy on Aura Biosciences Inc (AURA)
Aura Biosciences Inc: A Buy Rating on Strong Pipeline and Financial Health
Analysts Conflicted on These Healthcare Names: Sanofi (OtherSNYNF), Molina Healthcare (MOH) and Aura Biosciences Inc (AURA)
Analysts Offer Insights on Healthcare Companies: Aura Biosciences Inc (AURA), Spectral AI (MDAI) and Pyxis Oncology (PYXS)
Analysts Are Bullish on Top Healthcare Stocks: Aura Biosciences Inc (AURA), Altimmune (ALT)
BTIG Reaffirms Their Buy Rating on Aura Biosciences Inc (AURA)
BTIG Maintains Buy on Aura Biosciences, Lowers Price Target to $21
Aura Biosciences Analyst Ratings
Aura Biosciences Analyst Ratings
Positive Prospects for Aura Biosciences Inc. Despite Price Target Reduction: An Outperform Rating Maintained
Analysts' Top Healthcare Picks: Aura Biosciences Inc (AURA), Stereotaxis (STXS)
JMP Securities Sticks to Their Buy Rating for Aura Biosciences Inc (AURA)
Analysts Offer Insights on Healthcare Companies: Aura Biosciences Inc (AURA), Guardant Health (GH) and Day One Biopharmaceuticals (DAWN)
Promising Phase 2 Trial Results and Market Potential Bolster Aura Biosciences' Buy Rating
Scotiabank Keeps Their Buy Rating on Aura Biosciences Inc (AURA)
Analysts' Opinions Are Mixed on These Healthcare Stocks: IQVIA Holdings (IQV), Danaher (DHR) and Aura Biosciences Inc (AURA)
Promising Phase 2 Results Bolster Confidence in Aura Biosciences' Choroidal Melanoma Treatment: A Buy Rating Recommendation
Aura Biosciences Inc (AURA) Receives a Buy From JMP Securities
Scotiabank Initiates Coverage On Aura Biosciences With Sector Outperform Rating, Announces Price Target of $23
Aura Biosciences Analyst Ratings
No Data